IFP Advisors, Inc - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 5 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2021$000.00%
Q1 2021$000.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q4 2018$8,000
-42.9%
5,5000.0%0.00%
-100.0%
Q3 2018$14,000
-22.2%
5,5000.0%0.00%0.0%
Q2 2018$18,000
+1700.0%
5,500
+1150.0%
0.00%
Q3 2016$1,0000.0%4400.0%0.00%
Q2 2016$1,000
-50.0%
440
-18.5%
0.00%
Q4 2015$2,0005400.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
MARATHON CAPITAL MANAGEMENT 55,000$179,0000.09%
WEDBUSH SECURITIES INC 180,945$590,0000.09%
Brown Advisory Securities, LLC 28,000$91,0000.03%
FNY Managed Accounts LLC 8,000$26,080,0000.02%
FT Options LLC 10,000$26,0000.02%
WEBSTER BANK, N. A. 40,000$130,0000.02%
GSA CAPITAL PARTNERS LLP 30,907$101,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$82,0000.00%
NATIONAL PLANNING CORP 11,000$32,0000.00%
Virtu KCG Holdings LLC 24,705$81,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders